EFECTOS DE LOS MEDICAMENTOS CARDIOVASCULARES SOBRE EL GLOBO OCULAR / Effects of cardiovascular drugs on the eyeball

EFECTOS DE LOS MEDICAMENTOS CARDIOVASCULARES SOBRE EL GLOBO OCULAR / Effects of cardiovascular drugs on the eyeball

Resumen Introducción y objetivos: A las consultas de Oftalmología acuden pacientes con una alta incidencia de enfermedades cardiovasculares y muchos de los fármacos útiles para este tipo de afecciones pueden producir efectos indeseables sobre el globo ocular. El objetivo de esta investigación fue de...

Full description

Bibliographic Details
Main Authors:	Caridad Peraza Martínez, Ediel Peraza Martínez, Reinaldo Rodríguez Camiño, Lourdes M. Moreno Pérez
Format:	Article
Language:	English
Published:	Cardiocentro Ernesto Che Guevara 2013-01-01
Series:	CorSalud
Subjects:	Cardiovascular Agents/ adverse effects Cardiovascular Agents/ contraindications Eye Diseases/ chemically induced Eye Diseases/ etiology
Online Access:	http://bvs.sld.cu/revistas/cors/pdf/2013/v5n1a13/es/globocular.pdf

Similar Items

Prescription patterns of diclofenac in patients with cardiovascular diseases or at high risk for cardiovascular diseases at primary health care level in Montenegro: Retrospective, national, drug utilization study
by: Stanković Maja, et al.
Published: (2023-01-01)

Persistence and Adherence to Cardiovascular Medicines in Australia
by: Juliana de Oliveira Costa, et al.
Published: (2023-07-01)

Effectiveness of diet and exercise intervention programs on cardiovascular disease risk factors among postmenopausal Iranian women
by: Abedi, Parvin
Published: (2009)

Cardiovascular disease in rheumatic diseases
by: E L Nasonov, et al.
Published: (2016-05-01)

Contraindications and factors that rule out patients willing to undergo laser vision correction
by: Jan Łoginoff, et al.
Published: (2023-05-01)

Socio-economy, lifestyle, nutritional status, biochemical parameters and blood pressure associated with cardiovascular disease risk markers among Malay employees in Universiti Putra Malaysia
by: Abd. Azimi, Norshafawati
Published: (2013)

Research Progress and Potential Applications of Spermidine in Ocular Diseases
by: Wentao Han, et al.
Published: (2022-07-01)

Ranolazine: A true pluripotent cardiovascular drug or jack of all trades, master of none?
by: Alice Mezincescu, et al.
Published: (2018-04-01)

The cardiovascular adrenergic system /
by: Lymperopoulos, Anastasios, http://id.loc.gov/authorities/names/n2015185196 editor., et al.
Published: (2015)

DOCTOR’S ADHERENCE TO RECOMMENDATIONS GOVERNING THE ANTIPLATELET AGENTS USE IN THE CARDIOVASCULAR DISEASES PREVENTION AND TREATMENT
by: N. В. Perepech, et al.
Published: (2018-05-01)

La apoptosis y el sistema cardiovascular. Apoptosis and the cardiovascular system.
by: Alberto Hernández Cañero, et al.
Published: (1998-01-01)

Cardiovascular Considerations in Antidepressant Therapy: An Evidence-Based Review
by: Habibeh Yekehtaz, et al.
Published: (2015-10-01)

Prevalence of cardiovascular events among patients with type 2 diabetes in the west region of Saudi Arabia
by: Abdullah A. Assiri, et al.
Published: (2022-12-01)

Air pollution and its impact on the cardiovascular system
by: Marjorie Paris Colombini
Published: (2008-03-01)

The Cardiovascular Adrenergic System / edited by Anastasios Lymperopoulos
by: Lymperopoulos, Anastasios, editor
Published: (2015)

Frequency of Ocular Manifestation in Hemodialysis Patients
by: F Eslami, et al.
Published: (2017-06-01)

Treatment With Vasopressor Agents for Cardiovascular Shock Patients With Poor Renal Function; Results From the Japanese Circulation Society Cardiovascular Shock Registry
by: Tsukasa Yagi, et al.
Published: (2021-05-01)

Potential for Hospital Based Corneal Retreival in Hassan District Hospital
by: Kavitha Chikkanayakanahalli Venugopal, et al.
Published: (2015-08-01)

Pharmacological Treatment of Type-2-Diabetes and Cardiovascular Comorbidities: Differences between Undocumented Migrants and Natives in Italy
by: Gianfrancesco Fiorini, et al.
Published: (2022-12-01)

Prevalence of solar UV-provoked anterior segment eye diseases and association of risk factors among fishermen in Jazan, Saudi Arabia
by: Alibrahim, Ahmed I. A.
Published: (2017)

Effect of Biologics on Cardiovascular Inflammation: Mechanistic Insights and Risk Reduction
by: Fragoulis GE, et al.
Published: (2021-05-01)

Deprescribing preventive cardiovascular medication in patients with predicted low cardiovascular disease risk in general practice – the ECSTATIC study: a cluster randomised non-inferiority trial
by: Clare H. Luymes, et al.
Published: (2018-01-01)

Ocular Antibiotic Utilisation across Aotearoa/New Zealand
by: Isabella M. Y. Cheung, et al.
Published: (2023-06-01)

Relative Contributions of Arterial Stiffness and Hypertension to Cardiovascular Disease: The Framingham Heart Study
by: Teemu J. Niiranen, et al.
Published: (2016-10-01)

Acute poisoning by cardiovascular agents
by: Vučinić Slavica, et al.
Published: (2003-01-01)

Ocular pseudoexfoliation syndrome and life span
by: Jon Klokk Slettedal, et al.
Published: (2015-07-01)

Cardiovascular Effects of Saffron: An Evidence-Based Review
by: Maryam Kamalipour, et al.
Published: (2011-06-01)

Understanding deprescribing of preventive cardiovascular medication: a Q-methodology study in patients
by: Luymes CH, et al.
Published: (2017-05-01)

Contracepção hormonal e sistema cardiovascular Contracepción hormonal y sistema cardiovascular Hormonal contraception and cardiovascular system
by: Milena Bastos Brito, et al.
Published: (2011-04-01)

Snake Venom Components: Tools and Cures to Target Cardiovascular Diseases
by: Jacinthe Frangieh, et al.
Published: (2021-04-01)

Cardiovascular Effects of Saffron: An Evidence-Based Review
by: Shahin Akhondzadeh, et al.
Published: (2011-05-01)

Metabolomic phenotyping of obesity for profiling cardiovascular and ocular diseases
by: Pingting Zhong, et al.
Published: (2023-06-01)

Pathological changes of the eye retina at cardiovascular disease and diabetes mellitus
by: A. O. Direev, et al.
Published: (2020-06-01)

Novel Antithrombotic Agents in Ischemic Cardiovascular Disease: Progress in the Search for the Optimal Treatment
by: Ignacio Barriuso, et al.
Published: (2022-11-01)

The Association of Cardiovascular and Neurological Comorbidities in Geriatric Patients Sustaining Ocular Trauma
by: Pham VQ, et al.
Published: (2023-11-01)

SOME ASPECTS OF PRIMARY POSTTRAUMATIC EYEBALL REMOVAL
by: P. M. Balashova, et al.
Published: (2019-02-01)

Risk of Hospitalization for Cardiovascular Events with β-Blockers in Hypertensive Patients: A Retrospective Cohort Study
by: Jan Basile, et al.
Published: (2018-09-01)

Adverse drug reactions induced by cardiovascular drugs in outpatients
by: Gholami K, et al.
Published: (2008-03-01)

Dry eye disease: A review of anti-inflammatory therapies
by: Annie Nguyen, et al.
Published: (2023-01-01)

Uncontrolled and apparent treatment resistant hypertension: a cross-sectional study of Russian and Norwegian 40–69 year olds
by: Jakob Petersen, et al.
Published: (2020-03-01)